Interleukin-12 Requires Initial CD80-mediated T-Cell Activation to Support Immune Responses Toward Human Breast and Ovarian Carcinoma

Cancer Gene Therapy- United Kingdom

doi 10.1038/sj.cgt.7700050

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search